logo
  • Home
  • News
Menu

Biotechs are Awful and Caribou Biosciences Looks Reasonable

Home / Stock Analysis / Biotechs are Awful and Caribou Biosciences Looks Reasonable
Article feature image

Biotechs are Awful and Caribou Biosciences Looks Reasonable

26 Jul Stock Analysis

My foray into gene editing has been more miss than hit so far. I bought a few of these stocks four or so weeks ago and have subsequently watched them crumble along with the rest of biotech.
As of Friday I had positions in CRISPR Therapeutics and Intellia…

Click here to view the original article.

Tags:
Global, Reminiscencesofastockblogger.com
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186700183.jpeg
+

DIC (TSE:4631): Evaluating Valuation as Investor Interest Grows After Recent Share Price Movement

10 Oct Stock Analysis
6b0251c5316e2a9934aa0a125d622be7.jpeg
+

Wall Street tumbles toward its worst day since April after Trump threatens more tariffs on China

10 Oct Stock Analysis

recent post

  • kalshi20betting_id_23b5ce0e-b4ea-4d32-8caa-91f94ea47998_size900.jpg

    Kalshi Secures $300M; Plans Crypto Integration

    Oct 10 2025
  • 1585186700183.jpeg

    DIC (TSE:4631): Evaluating Valuation as Investor

    Oct 10 2025
  • Bitcoin-decrypt-style-27-gID_7.jpg

    Red Uptober? Crypto Liquidations Top $1

    Oct 10 2025
  • 6b0251c5316e2a9934aa0a125d622be7.jpeg

    Wall Street tumbles toward its worst

    Oct 10 2025
  • Machu-Picchu-Peru-Latin-America-sandro-ayalo-unsplash.jpg

    Digital Assets Infrastructure Firm BitGo Enables

    Oct 10 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.